Cargando…

miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib

BACKGROUND: Osteosarcoma (OSA), the most common primary bone malignancy, is characterized by a wide spectrum of complicated pathologies and frequent distal metastasis and causes death in adolescents and young adults worldwide. Antitumor drug treatment strategies include various cytotoxic chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Leisheng, En, He, Yang, Lei, Zhang, Yanbing, Sun, Baisheng, Gao, Jianjiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709039/ https://www.ncbi.nlm.nih.gov/pubmed/31686840 http://dx.doi.org/10.2147/OTT.S215145

Ejemplares similares

MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells
por: Chen, Xun, et al.
Publicado: (2016)

miR-596-3p suppresses brain metastasis of non-small cell lung cancer by modulating YAP1 and IL-8
por: Li, Chenlong, et al.
Publicado: (2022)

MiR-596 down regulates SOX4 expression and is a potential novel biomarker for gastric cancer
por: Chen, Yongyi, et al.
Publicado: (2020)

Plasma exosomal miR-596: a novel biomarker predicts survival in patients with idiopathic pulmonary artery hypertension
por: Huang, Yang, et al.
Publicado: (2021)

Targeting survivin using a combination of miR-494 and survivin shRNA has synergistic effects on the suppression of prostate cancer growth
por: ZHU, JIN, et al.
Publicado: (2016)

MiR-596 inhibits osteoblastic differentiation and cell proliferation by targeting Smad3 in steroid-induced osteonecrosis of femoral head
por: Fu, Ligong, et al.
Publicado: (2020)

MiR-596 activated by EP300 controls the tumorigenesis in epithelial ovarian cancer by declining BRD4 and KPNA4
por: Wang, Deying, et al.
Publicado: (2020)

NAIF1 suppresses osteosarcoma progression and is regulated by miR‐128
por: Kong, Daliang, et al.
Publicado: (2018)

MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression
por: Jingjing, Lin, et al.
Publicado: (2016)

MiR-429 suppresses the progression and metastasis of osteosarcoma by targeting ZEB1
por: Deng, Yi, et al.
Publicado: (2017)

miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway
por: He, Ming, et al.
Publicado: (2017)

miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway
por: He, Ming, et al.
Publicado: (2023)

Tumor Suppressive Role of miR-342-5p and miR-491-5p in Human Osteosarcoma Cells
por: Veys, Clément, et al.
Publicado: (2022)

Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma
por: Xu, Jiuhui, et al.
Publicado: (2023)

Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma
por: Nakka, Manjula, et al.
Publicado: (2017)

miR-142 suppresses proliferation and induces apoptosis of osteosarcoma cells by upregulating Rb
por: Gao, Yan-Fang, et al.
Publicado: (2018)

miR-9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16
por: Gao, Song, et al.
Publicado: (2019)

miR-1297 Suppresses Osteosarcoma Proliferation and Aerobic Glycolysis by Regulating PFKFB2
por: Pan, Xiaohui, et al.
Publicado: (2020)

Expression of miR-664 and miR-184 on proliferation, apoptosis and migration of osteosarcoma cells
por: Tao, Pengfei, et al.
Publicado: (2019)

MS‐275 potentiates the effect of YM‐155 in lung adenocarcinoma via survivin downregulation induced by miR‐138 and miR‐195
por: Luo, Bai‐Ling, et al.
Publicado: (2019)

miR-27-3p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to the Antitumor Agent Olaparib by Targeting PSEN-1, the Catalytic Subunit of Γ-Secretase
por: Zhao, Meng, et al.
Publicado: (2021)

miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1
por: Liu, Jianyong, et al.
Publicado: (2018)

MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2
por: Xie, Yuanlong, et al.
Publicado: (2017)

MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6
por: Zhu, Kegan, et al.
Publicado: (2016)

Long non-coding RNA TUSC7 suppresses osteosarcoma by targeting miR-211
por: Cong, Menglin, et al.
Publicado: (2019)

miR-193b exhibits mutual interaction with MYC, and suppresses growth and metastasis of osteosarcoma
por: Gao, Jinjian, et al.
Publicado: (2020)

miR-3195 suppresses the malignant progression of osteosarcoma cells via targeting SOX4
por: Liang, Jianwei, et al.
Publicado: (2023)

Survivin as a Prognostic Factor for Osteosarcoma Patients
por: Osaka, Eiji, et al.
Publicado: (2006)

The Tumor Suppressor Role of miR-124 in Osteosarcoma
por: Geng, Shuo, et al.
Publicado: (2014)

Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate
por: Jiang, Liangdong, et al.
Publicado: (2014)

MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma
por: Sun, Yangbai, et al.
Publicado: (2016)

miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells
por: Salah, Zaidoun, et al.
Publicado: (2015)

miR-125b and miR-100 Are Predictive Biomarkers of Response to Induction Chemotherapy in Osteosarcoma
por: Kubota, Daisuke, et al.
Publicado: (2016)

An internet survey of 2,596 people with fibromyalgia
por: Bennett, Robert M, et al.
Publicado: (2007)

METTL3-mediated m6A modification of circRNF220 modulates miR-330-5p/survivin axis to promote osteosarcoma progression
por: Liu, Feng, et al.
Publicado: (2023)

Downregulation of LncRNA SNHG7 Sensitizes Colorectal Cancer Cells to Resist Anlotinib by Regulating miR-181a-5p/GATA6
por: Pan, Deng, et al.
Publicado: (2023)

miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression
por: Du, Liuxue, et al.
Publicado: (2018)

miR-150 is downregulated in osteosarcoma and suppresses cell proliferation, migration and invasion by targeting ROCK1
por: Li, Chang-Hui, et al.
Publicado: (2017)

MiR-141-3p overexpression suppresses the malignancy of osteosarcoma by targeting FUS to degrade LDHB
por: Wang, Lei
Publicado: (2020)

miR-16-5p Suppresses Progression and Invasion of Osteosarcoma via Targeting at Smad3
por: Gu, Zhijian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tdc9fr23pn5pcdgrvr58n8t5vn